Home > Team > Staff > Dr.in Claudia Iannetti

Dr.in Claudia Iannetti

Staff

Consultant

E-mail
claudia.iannetti@tirol-kliniken.at
Birth date
1973
Nationality
Austria

University Degree(s)

1992
1998
Medical studies at the University "G. D'Annunzio" in Chieti, Italy; summa cum laude

Professional Development

1998
Doctoral thesis: "The surgical treatment of pulmonary metastases"
1999
Licence to practise medicine (Modena, Italy)
1999
2007
Training as a specialist in general surgery: University Hospital for General Surgery, Policlinico Modena, Italy, Department of General Surgery, Arcispedale S. Maria Nuova in Reggio Emilia, Italy, University Hospital Innsbruck, Clinical Department for General and Transplant Surgery;
2007
2009
Specialist at the Medical University of Innsbruck, University Hospital for Visceral, Transplant and Thoracic Surgery
08/2009
-
Senior physician at the University Clinic for Visceral, Transplant and Thoracic Surgery
02/2020
-
Head of the Surgical Breast Outpatient Clinic

Additional Training, additional Professional Title

2001
”International Master of Laparoscopic Surgery of Gastroesophageal Reflux and inguinal Hernia”, Aesculap Akademie Institute of Tuttlingen (Germany) 2001
2001
A.C.O.I. Theoretic and Practical Course of Laparoscopic Surgery, Milan 2001 Dissertation: ”Vertical gastroplastic like McLean. Surgical Technique.”
2003
Intensive Course of Transplantation Medicine (Walter-Brendel-College for Transplantation Medicine), Wildbad Kreuth/Tegernsee
2003
2004
Advanced Training in Organ Transplantation Course from the European College of Transplantation (Official ESOT Training Course), Basel November 2003 and Berlin June 2004
2009
Course for nutritional medicine (Univ.-Doz. Dr. Maximilian Ledochowski)
2010
2011
Acupuncture course (ÖGA), so far attendance of the A1, A2, B1, B2, B3 and C courses
1016
Emergency physician training
2019
Completed ÖAK diploma for course in palliative medicine

Clinical focus

Pharmacologist in the double blind study phase II “Open-Label andomized, Controlled, Multiple-Dose Study of Efficacy and Safety of BMS-224818 as a part of Quadruple Drug Regimen in First renal Transplant Recipients (Sponsor Bristol-Myers Squibb)”
Co-investigator in the clinical randomized study, phase III, TERRA (Tacrolimus Evaluation in Renal Transplantation with Rapamune ) (Sponsor Fujisawa GmbH)
Co-investigator in the european clinical randomized study SYMPHONY in renal transplantation recipients (ELiTE)
Investigator in the clinical randomized ABCSG 26 - study SOLE (IBCSG 35-07)
2007
-
Senology focus

Publications

3 PubMed-listed original articles
open URL